(¿Â¶óÀÎ)´ëÇÑÁ¾¾ç³»°úÇÐȸ 7/7 ºÐ±âÁý´ãȸ : 2022-07-07±³À°ÀÏÀÚ : 2022-07-07
±³À°Àå¼Ò : ¿Â¶óÀÎÄÁÆÛ·±½º (½Ãû°¢ Àåºñ ÀÖÀ½)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)´ëÇÑÁ¾¾ç³»°úÇÐȸ 7/7 ºÐ±âÁý´ãȸÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
meetings@ksmo.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-07 ºñ¾ØµðÆÄÆ®³Ê½º(¼¿ï¿ª½ºÆ©µð¿À) 18:00~18:40 When should we order Genomic profiling for breast cancer patients? ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 07-07 ºñ¾ØµðÆÄÆ®³Ê½º(¼¿ï¿ª½ºÆ©µð¿À) 18:40~19:20 Who benefits from palliative mastectomy in advanced breast cancer patients? Á¤½ÂÇÊ(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 07-07 ºñ¾ØµðÆÄÆ®³Ê½º(¼¿ï¿ª½ºÆ©µð¿À) 19:20~20:00 Actionable mutations in GU cancers ±èÀÎÈ£(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 07-07 ºñ¾ØµðÆÄÆ®³Ê½º(¼¿ï¿ª½ºÆ©µð¿À) 20:00~21:00 Salvage treatment in advanced germ cell tumors: are they still curable? ¹Ú±Ç¿À(¾ç»êºÎ»ê´ëº´¿ø)